|
CN107460174A
|
|
Treat or prevent the active ingredient panted, composition containing the active ingredient and application thereof
|
|
TW201739466A
|
|
Active ingredient for treatment or prevention of asthma
|
|
CN105816484A
|
|
Composition used for preventing peritonitis and reducing deterioration of renal function for peritoneal dialysis patients
|
|
US2015166644A1
|
|
Dermatophagoid pteronyssinus (derp1) antigen epitope and anti-der p1 antibody
|
|
TW201519901A
|
|
Active ingredient for treatment or prevention of allergic diseases
|
|
TW201519796A
|
|
For peritoneal dialysis patients to prevent peritonitis and reduce the deterioration of renal function of the composition
|
|
TW201400123A
|
|
Use of Lactobacillus gasseri PM-A0005 in manufacturing a composition for enhancing PPAR γ expression
|
|
TW201247211A
|
|
A composition for preventing necrotizing enterocolitis
|
|
CN101328468A
|
|
Antiallergic lactic acid bacteria
|
|
TW200829175A
|
|
Anti-allergy lactic acid bacteria
|
|
TW201210509A
|
|
Anti-allergy lactic acid bacteria
|
|
US2006148034A1
|
|
Method for preventing and/or treating viral infection in aquatic animals
|
